Cited by 114Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Atrial flutter in patients treated for atrial fibrillation with propafenone

Murdock, Challon J., Kyles, Alison E., Yeung-Lai-Wah, John A., Qi, Anzhen, Vorderbrugge, Shirley, Kerr, Charles R.·1990·The American Journal of Cardiology

DOI 10.1016/0002-9149(90)91144-u

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/0002-9149(90)91144-u

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac Preparations
Ledda, F., Mantelli, L., Manzini, S., Amerini, S., & Mugelli, A. (1981) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198111000-00002 · Cited by 126
Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment
Crijns, H. J., van Gelder, I. C., & Lie, K. I. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90282-2 · Cited by 120
Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter
Antman, E. M., Beamer, A. D., Cantillon, C. O., McGowan, N. E., Goldman, L., & Friedman, P. L. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90468-8 · Cited by 116
Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone
Keller, K., Meyer-Estorf, G., Beck, O. A., & Hochrein, H. A. (1978) · European Journal of Clinical Pharmacology · doi:10.1007/bf00606676 · Cited by 65
Propafenone for paroxysmal atrial fibrillation
Hammill, S. C., Wood, D. L., Gersh, B. J., Osborn, M. J., & Holmes, D. R. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90312-8 · Cited by 65
Propafenone for prevention of recurrent atrial fibrillation
Kerr, C. R., Klein, G. J., Axelson, J. E., & Cooper, J. C. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90373-6 · Cited by 62
Self-citation

Show all 6 references

Sorted by citations

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)
Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström‐Lundqvist, C., Calkins, H. G., Corrado, D., Deftereos, S. G., Diller, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,312
Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation
Chugh, A., Oral, H., Lemola, K., Hall, B., Cheung, P., Good, E., Tamirisa, K., Han, J., Bogun, F., Pelosi, F., et al. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.01.027 · Cited by 338
Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension
Capucci, A., Lenzi, T., Boriani, G., Trisolino, G., Binetti, N., Cavazza, M., Fontana, G. A., & Magnani, B. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91392-h · Cited by 227
Gender-related differences in catheter ablation of atrial fibrillation
Forleo, G. B., Tondo, C., De Luca, L., Russo, A. D., Casella, M., De Sanctis, V., Clementi, F., Fagundes, R. L., Leo, R., Romeo, F., et al. (2007) · EP Europace · doi:10.1093/europace/eum144 · Cited by 189
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., et al. (2017) · Europace · doi:10.1093/europace/euw301 · Cited by 188
Proarrhythmia in Patients Treated for Atrial Fibrillation or Flutter
Falk, R. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-141 · Cited by 184
Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide
Capucci, A., Boriani, G., Botto, G. L., Lenzi, T., Rubino, I., Falcone, C., Trisolino, G., Casa, S. D., Binetti, N., Cavazza, M., et al. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90915-6 · Cited by 172
Effects of Oral Propafenone Administration Before Electrical Cardioversion of Chronic Atrial Fibrillation: A Placebo-Controlled Study
Bianconi, L., Mennuni, M., Lukic, V., Castro, A., Chieffi, M., & Santini, M. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00230-6 · Cited by 165
Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation
Capucci, A. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1734 · Cited by 155
A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm
Capucci, A., Boriani, G., Rubino, I., Casa, S. D., Sanguinetti, M., & Magnani, B. (1994) · International Journal of Cardiology · doi:10.1016/0167-5273(94)90211-9 · Cited by 127
Radiofrequency Catheter Ablation of Common Atrial Flutter
Anselme, F., Saoudi, N. C., Poty, H., Douillet, R., & Cribier, A. G. (1999) · Circulation · doi:10.1161/01.cir.99.4.534 · Cited by 121
Propafenone for Conversion of Recent-Onset Atrial Fibrillation
Boriani, G., Capucci, A., Lenzi, T., Sanguinetti, M., & Magnani, B. (1995) · CHEST Journal · doi:10.1378/chest.108.2.355 · Cited by 110
Catheter Ablation of Atypical Atrial Flutter and Atrial Tachycardia Within the Coronary Sinus After Left Atrial Ablation for Atrial Fibrillation
Chugh, A., Oral, H., Good, E. D., Han, J. D., Tamirisa, K. P., Lemola, K., Elmouchi, D., Tschopp, D. R., Reich, S., Igic, P., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.053 · Cited by 109
Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation: Results of a randomized, double-blind, controlled study
Azpitarte, J., Alvarez, M., Baun, R. F., García, R., Moreno, E., Martin, F., Tercedor, L., & Fernandez, R. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015146 · Cited by 105
Thromboembolism in Chronic Atrial Flutter: Is the Risk Underestimated?
Lanzarotti, C. J., & Olshansky, B. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00326-4 · Cited by 103
The Treatment of Atrial Fibrillation
Nattel, S., Hadjis, T., & Talajic, M. R. (1994) · Drugs · doi:10.2165/00003495-199448030-00003 · Cited by 102
Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation
Schumacher, B. M., Jung, W., Lewalter, T., Vahlhaus, C., Wolpert, C., & Lüderitz, B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00975-8 · Cited by 101
Conversion of Recent-Onset Atrial Fibrillation by a Single Oral Dose of Pilsicainide ( Pilsicainide Suppression Trial on Atrial Fibrillation)
Atarashi, H., Inoue, H., Hiejima, K., & Hayakawa, H. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00401-8 · Cited by 100
Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation
Siu, C.-W., Lau, C.-P., Lee, W.-L., Lam, K.-F., & Tse, H.-F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a02f56 · Cited by 96
Pharmacological Cardioversion of Atrial Fibrillation
Boriani, G., Diemberger, I., Biffi, M., Martignani, C., & Branzi, A. (2004) · Drugs · doi:10.2165/00003495-200464240-00003 · Cited by 91
Propafenone
Bryson, H. M., Palmer, K. J., Langtry, H. D., & Fitton, A. (1993) · Drugs · doi:10.2165/00003495-199345010-00008 · Cited by 78
Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens
Botto, G. L., Capucci, A., Bonini, W., Boriani, G., BROFFONI, T., Barone, P., Espureo, M., Lombardi, R., Molteni, S., & Ferrari, G. M. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)02841-0 · Cited by 77
Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm:
Capucci, A., VILLANI, G. Q., Aschieri, D., & Piepoli, M. F. (1999) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00363-5 · Cited by 71
Proarrhythmia
Friedman, P. L., & Stevenson, W. G. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00586-4 · Cited by 70
Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation
Blanc, J., Voinov, C., & Maarek, M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00493-2 · Cited by 69
The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation
Marcus, G. M. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90851-q · Cited by 69
Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation
Bianconi, L., & Mennuni, M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00412-3 · Cited by 62
Effectiveness of intravenous propafenone for conversion of recent‐onset atrial fibrillation: A placebo‐controlled study
Bellandi, F., Cantini, F., Pedone, T., Palchetti, R., Bamoshmoosh, M., & Dabizzi, R. P. (1995) · Clinical Cardiology · doi:10.1002/clc.4960181108 · Cited by 62
Persistent Atrial Flutter in Patients Treated for Atrial Fibrillation with Amiodarone and Propafenone: Electrophysiologic Characteristics, Radiofrequency Catheter Ablation, and Risk Prediction
TAI, C., CHIANG, C., LEE, S., CHEN, Y., YU, W., FENG, A., DING, Y., CHANG, M., & CHEN, S. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00293.x · Cited by 60
The Alternation between Atrial Flutter and Atrial Fibrillation
Tunick, P. A., McElhinney, L., Mitchell, T., & Kronzon, I. (1992) · CHEST Journal · doi:10.1378/chest.101.1.34 · Cited by 57
Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias
Brembilla-Perrot, B., Houriez, P., Beurrier, D., Claudon, O., Chaise, A. T. D. L., & Louis, P. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00459-4 · Cited by 56
Regular Ventricular Rhythms Before Conversion of Recent Onset Atrial Fibrillation to Sinus Rhythm
Botto, G., Bonini, W., BROFFONI, T., CAPPELLETTI, G. A., Falcone, C., LOMBARDI, R., Paulesu, A., PEDRAGLIO, E., & Ferrari, G. M. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb03810.x · Cited by 56
Clinical Pharmacokinetics of Propafenone
Hii, J. T. Y., Duff, H. J., & Burgess, E. D. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199121010-00001 · Cited by 55
Comparisons of Oral Propafenone and Sotalol as an Initial Treatment in Patients With Symptomatic Paroxysmal Atrial Fibrillation
Lee, S.-H., Chen, S., TAI, C., Chiang, C., Wen, Z., Chen, Y., Yu, W., Huang, J., Fong, A.-N., Cheng, J.-J., et al. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00025-8 · Cited by 54
Acute Treatment of Atrial Fibrillation
Kowey, P. R., Marinchak, R. A., Rials, S. J., & Filart, R. A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00182-9 · Cited by 53
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination
Biffi, M., Boriani, G., Bronzetti, G., Capucci, A., Branzi, A., & Magnani, B. (1999) · Heart · doi:10.1136/hrt.82.2.176 · Cited by 47
Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation
Stabile, G., De Simone, A., Turco, P., La Rocca, V., Nocerino, P., Astarita, C., Maresca, F., De Matteis, C., Di Napoli, T., Stabile, E., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01214-1 · Cited by 46
Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: A single-blind, randomized, controlled study
VILLANI, G. Q., Piepoli, M. F., Terracciano, C. M., & Capucci, A. (2000) · American Heart Journal · doi:10.1067/mhj.2000.107179 · Cited by 44
Conversion of Recent Onset Atrial Fibrillation with Single Loading Oral Dose of Propafenone: Is In‐Hospital Admission Absolutely Necessary?
Botto, G. L., Bonini, W., BROFFONI, T., Molteni, S., LOMBARDI, R., ALFIERI, G., Barone, P., Bernasconi, G., & Ferrari, G. M. (1996) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1996.tb03257.x · Cited by 44
Antiarrhythmic Drug Therapy in the Management of Atrial Fibrillation
Ganz, L. I., & Antman, E. M. (1997) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1997.tb01005.x · Cited by 38
Randomized, Crossover, Controlled Comparison of Oral Loading Versus Intravenous Infusion of Propafenone in Recent‐Onset Atrial Fibrillation
Botto, G. L., Bonini, W., BROFFONI, T., Espureo, M., CAPPELLETTI, G. A., Lombardi, R., Molteni, S., PEDRAGLIO, E., & Ferrari, G. M. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb01205.x · Cited by 36
Propafenone in the Treatment of Cardiac Arrhythmias
Capucci, A., & Boriani, G. (1995) · Drug Safety · doi:10.2165/00002018-199512010-00005 · Cited by 35
Risk of Complications of Atrial Fibrillation
Capucci, A., VILLANI, G. Q., & Aschieri, D. (1997) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1997.tb06117.x · Cited by 33
Oral Loading with Propafenone for Conversion of Recent-Onset Atrial Fibrillation
Boriani, G., Martignani, C., Biffi, M., Capucci, A., & Branzi, A. (2002) · Drugs · doi:10.2165/00003495-200262030-00001 · Cited by 30
New Approaches to Treatment of Atrial Flutter and Tachycardia
Lesh, M. D., Kalman, J. M., & Olgin, J. E. (1996) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1996.tb00539.x · Cited by 31
Limitations to antiarrhythmic drug use in patients with atrial fibrillation
Humphries, K. H. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031277 · Cited by 30
Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs
Kawabata, M., Hirao, K., Horikawa, T., Suzuki, K., Motokawa, K., Suzuki, F., Azegami, K., & Hiejima, K. (2001) · Journal of Electrocardiology · doi:10.1054/jelc.2001.22034 · Cited by 29
Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 34
Atypical atrial flutter: clinical features, electrophysiological characteristics and response to radiofrequency catheter ablation
Bella, P. E. D. (2002) · EP Europace · doi:10.1053/eupc.2002.0242 · Cited by 27
Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment
Riva, S. I. (1999) · EP Europace · doi:10.1053/eupc.1999.0048 · Cited by 25
Outcome after cavo-tricuspid isthmus ablation in patients with recurrent atrial fibrillation and drug-related typical atrial flutter
Bottoni, N., Donateo, P., Quartieri, F., Tomasi, C., Oddone, D., Lolli, G., Menozzi, C., & Brignole, M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.04.069 · Cited by 24
Propafenone: An Effective Agent for the Management of Supraventricular Arrhythmias
Grant, A. O. (1996) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1996.tb00537.x · Cited by 23
Intravenous propafenone: Efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation—A single-blind placebo-controlled study
Bellandi, F., Dabizzi, R. P., Cantini, F., Natale, M., & Niccoli, L. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00823593 · Cited by 23
Atypical atrial flutter: review of mechanisms, advances in mapping and ablation outcomes
Ko, N. L. K., Sriramoju, A., Khetarpal, B. K., & Srivathsan, K. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000924 · Cited by 21
Atrial fibrillation after typical atrial flutter ablation: a long-term follow-up
Bandini, A., Golia, P., Caroli, E., Biancoli, S., & Galvani, M. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283403301 · Cited by 20
Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect
Tamargo, J. L., Pérez‐Villacastín, J., Caballero, R., & Delpón, E. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107077 · Cited by 22
Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias
Rae, A. P. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00739-5 · Cited by 19
The treatment of atrial fibrillation: Pharmacologic and nonpharmacologic strategies
Viskin, S., Barron, H. V., Heller, K., Scheinman, M. M., & Olgin, J. E. (1997) · Current Problems in Cardiology · doi:10.1016/s0146-2806(97)80014-x · Cited by 19
Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses
Carstensen, H., Hesselkilde, E. M., Fenner, M. F., Loft‐Andersen, A. V., Flethøj, M., Kanters, J. K., Sattler, S. M., Tfelt‐Hansen, J., Pehrson, S. M., Jespersen, T., et al. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15287 · Cited by 18
THE MEDICAL MANAGEMENT OF ATRIAL FIBRILLATION
Masoudi, F. A., & Goldschlager, N. (1997) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70370-2 · Cited by 17
Antiarrhythmic drug initiation in patients with atrial fibrillation
Pinski, S. L., & Helguera, M. E. (1999) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(99)70010-1 · Cited by 14
A comparison of propafenone and amiodarone in reversion of recent-onset atrial fibrillation to sinus rhythm
Negrini, M., Gibelli, G., & Ponti, C. D. (1994) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80319-4 · Cited by 13
Intravenous antiarrhythmic agents
Pintér, A., & Dorian, P. (2001) · Current Opinion in Cardiology · doi:10.1097/00001573-200101000-00003 · Cited by 13
Clinical Pharmacology of Antiarrhythmic Drugs
Capucci, A., Aschieri, D., & VILLANI, G. Q. (1998) · Drugs & Aging · doi:10.2165/00002512-199813010-00006 · Cited by 13
Oral antiarrhythmic drugs in converting recent onset atrial fibrillation
Deneer, V. H. M., Borgh, M. B. I., Kingma, J. H., Lie‐A‐Huen, L., & Brouwers, J. R. B. J. (2004) · Pharmacy World & Science · doi:10.1023/b:phar.0000018593.02291.c0 · Cited by 12
Drugs after Cardioversion to Prevent Relapses of Chronic Atrial Fibrillation or Flutter
Crijns, H. J. G. M., Gosselink, A. T. M., Gelder, I. C. V., Wiesfeld, A. C. P., van den Berg, M. P., Tuininga, Y. S., & Lie, K. I. (1992) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1816-3_7 · Cited by 11
Selection of patients with secundum atrial septal defects for transcather device closure
Qureshi, S. A. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1972 · Cited by 11
Electrocardiographic and Electrophysiological Characteristics of Atrial Fibrillation Organized Into Atrial Flutter by Oral Administration of Class I Antiarrhythmic Agents
Ohmura, K., Kobayashi, Y., Miyauchi, Y., Endoh, Y., Atarashi, H., Katoh, T., & Takano, T. (2003) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2003.00119.x · Cited by 8
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias
Katritsis, D. G., Boriani, G., Cosío, F. G., Jaı̈s, P., Hindricks, G., Josephson, M. E., Keegan, R., Knight, B. P., Kück, K., Lane, D. A., et al. (2016) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:5.3.gl1 · Cited by 7
Rapid Ventricular Response Due to Treatment of Atrial Flutter or Fibrillation with Class IC Antiarrhythmic Drugs
Mackstaller, L. L., & Marcus, G. M. (2000) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2000.tb00254.x · Cited by 7
Long‐term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide‐induced atrial flutter
Hirao, K., Okishige, K., Yamamoto, N., Otomo, K., Azegami, K., & Isobe, M. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280707 · Cited by 7
New Options for Pharmacological Conversion of Atrial Fibrillation
Boriani, G. (2001) · Cardiac Electrophysiology Review · doi:10.1023/a:1011488918280 · Cited by 6
Intravenous Propafenone for Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm: A Randomized, Placebo-controlled, Crossover Study
Fak, A. S., Tezcan, H., Caymaz, O., Tokay, S., Oktay, Ş., & Oktay, A. A. (1997) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424849700200403 · Cited by 6
Positive inotropic drugs and drugs used in dysrhythmias
Aronson, J. K. (2004) · Side effects of drugs annual · doi:10.1016/s0378-6080(04)80024-2 · Cited by 6
Clinical Characteristics of Atrial Flutter and Its Response to Pharmacological Cardioversion with Amiodarone in Comparison to Atrial Fibrillation
Wybraniec, M. T., Górny, K., Jabłoński, K., Jung, J., Rabtsevich, K., Szyszka, P., Wesołek, F., Bula, K., Cichoń, M., Wróbel, W., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134262 · Cited by 5
Pharmacological cardioversion of atrial fibrillation: practical considerations
Wybraniec, M. T., Kampka, Z., & Mizia‐Stec, K. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16547 · Cited by 6
Non-Invasive Characteristics of Atrial Fibrillation: The Value of Holter Recordings for the Treatment of AF
WIJFFELS, M. C. E. F., & Crijns, H. J. G. M. (2002) · Cardiac Electrophysiology Review · doi:10.1023/a:1016324908012 · Cited by 5
Management of superior vena caval obstruction secondary to a pacing wire with percutaneous intravascular stent insertion
Melikian, N., Brookes, C. I. O., & Rickards, A. F. (1999) · Heart · doi:10.1136/hrt.82.2.182 · Cited by 5
Evaluación de la fibrilación auricular mediante electrocardiograma y Holter
Mora-Pabón, G. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.10.006 · Cited by 4
Hybrid Therapy in the Management of Atrial Fibrillation
Stárek, Z., Lehár, F., Jež, J., Wolf, J., & Novák, M. (2014) · Current Cardiology Reviews · doi:10.2174/1573403x10666140713172231 · Cited by 3
Aggravation of Arrhythmia by Antiarrhythmic Drugs (Proarrhythmia)
Podrid, P. J. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.06.006 · Cited by 3
Plasma viscosity, fibrinogen, white cell count, and cardiovascular risk factors.
Jay, R. H., RAMPLING, M. W., & Betteridge, D. J. (1992) · Circulation · doi:10.1161/circ.85.5.1572057 · Cited by 3
Management of Intermittent Atrial Fibrillation
Olgin, J. E., & VISKIN, S. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00697.x · Cited by 3
Medikamentöse Kardioversion von Vorhofflimmern
Ehrlich, J. R., & Hohnloser, S. H. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0166-9 · Cited by 3
Positive inotropic drugs and drugs used in dysrhythmias
Aronson, J. K. (1992) · Side effects of drugs annual · doi:10.1016/s0378-6080(05)80498-2 · Cited by 3
Diretriz Brasileira de Fibrilação Atrial – 2025
Cintra, F. D., Pisani, C. F., Rezende, A. G. D. S., Henz, B. D., Armaganijan, L., Pimentel, M., Lópes, R. D., do Nascimento, T. A., Lorga-Filho, A. M., de Albuquerque, A., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250618 · Cited by 21
Antithrombotic therapy in atrial flutter: To anticoagulate or not, that is the question
Wesołek, F., Szyszka, P., Cichoń, M., Mizia‐Stec, K., & Wybraniec, M. T. (2024) · Heart Rhythm O2 · doi:10.1016/j.hroo.2024.11.003 · Cited by 2
Fibrinogen, viscosity, and white blood cell count.
Ernst, E. (1992) · Circulation · doi:10.1161/circ.85.5.1572056 · Cited by 2
The Effects of a Bidirectional Cavo-Tricuspid Isthmus Block in Persistent Atrial Fibrillation
Kim, J., Choi, S., Joung, B., Lee, M., & Kim, S. S. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.1.76 · Cited by 1
Ablacja cieśni trójdzielno-żylnej wśród pacjentów z przetrwałym migotaniem przedsionków jako terapia pomostowa celem utrzymania rytmu zatokowego — badanie pilotażowe
Adamowicz, J., Szponder, M., Sokołowska, M., Sławuta, A., Gajek, J. J., & Zyśko, D. (2017) · Folia Cardiologica · doi:10.5603/fc.2017.0051 · Cited by 1
The characteristics of pre‐excitation syndrome concomitant with atrial tachyarrhythmia and the effect of radiofrequency ablation
Cui, C., Li, Z., Ju, W., Yang, G., Gu, K., Liu, H., Li, M., Chen, H., Wang, J., & Chen, M. (2022) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14598 · Cited by 1
Wide QRS complex tachycardia with a mysterious mask—Tricuspid isthmus‐dependent atrial flutter with preexcitation syndrome and dual atrioventricular nodal pathway conduction
Liu, C., Li, C., Xu, X., Zhou, M., Huang, X., Zhou, B., Cao, J., Huang, S., & Guo, Z. (2023) · Clinical Case Reports · doi:10.1002/ccr3.8202 · Cited by 1
Trends in Management of Atrial Fibrillation
Kerr, C. R., Yeung‐Lai‐Wah, J. A., & Leather, R. A. (1992) · Springer eBooks · doi:10.1007/978-3-662-30492-1_7 · Cited by 1
Self-citation
Hybrid pharmacological and ablative therapy for the management of symptomatic atrial fibrillation.
Kimman, G. P., Szili‐Törok, T., Nieuwdorp, M., Theuns, D. A. M. J., SCHOLTEN, M. F., & Jordaens, L. J. L. M. (2002) · PubMed Central · Cited by 1
Hybrid theraphy for atrial fibrillation
Geelen, P. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1976 · Cited by 1
Acute Termination of Atrial Flutter: Are New Class Antiarrhythmic Drugs the Best Choice?
Baldi, N., Russo, V., Morrone, V., Gregorio, L. D., Liconso, L., & Polimeni, G. (2002) · Springer eBooks · doi:10.1007/978-88-470-2103-7_43
Baseline drug history is also important for interpretation of the electrocardiogram
Jolobe, O. M. P. (2010) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2010.04.009
Clinical Efficacy of Bepridil for Class I Antiarrhythmic Drug-Induced Atrial Flutter in Patients with Paroxysmal Atrial Fibrillation
Hayashi, H., Sumiyoshi, M., Suwa, S., Sakurai, H., Kawano, Y., Sekita, G., Tokano, T., Nakazato, Y., & Daida, H. (2008) · Journal of Arrhythmia · doi:10.1016/s1880-4276(08)80011-7
Elektrophysiologische Grundlagen der Hybrid-Therapie: Wie kommt es zur Konversion von Vorhofflimmern in Vorhofflattern?
Schumacher, B. M., & Neuser, H. (2003) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-003-0367-8

Authors: Murdock, C. J., Kyles, A. E., Yeung-Lai-Wah, J. A., Qi, A., Vorderbrugge, S., & Kerr, C. R.
Affiliations: University of British Columbia Hospital (CA)
Venue: The American Journal of Cardiology
Publisher: Elsevier BV
Published: 1990-09
Volume: 66
Issue: 7
Pages: 755-757
ISSN: 0002-9149 (ISSN-L)
DOI: 10.1016/0002-9149(90)91144-u
OpenAlex: W2056431470
Cited by: 114
References: 6
Citations by year: 2026: 1 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 3 · 2014: 1
FWCI: 4.13
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The American Journal of Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: atrial flutter, propafenone, atrial fibrillation, class Ic antiarrhythmic drugs, ventricular response, adverse drug reactions, atrial fibrillation recurrence
MeSH terms: Atrial Fibrillation, Atrial Flutter, Electrocardiography, Follow-Up Studies, Heart Rate, Humans, Propafenone, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Atrial flutter in patients treated for atrial fibrillation with propafenone

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks